About the company
Macrocyclics, Inc., a manufacturer of customized chelating agents, is dedicated to leading-edge development of new chelation chemistry platforms critical for advancement of diagnostic and therapeutic medicine.
Providing tools and solutions in the field of nuclear medicine for site-specific bioconjugation, advanced chelating agent technology, and peptide intermediates.
Macrocyclics introduced its cGMP manufacturing services in 2005. Our quality system is designed specifically for the manufacture of APIs to be used in clinical trials.
Stay informed on new technology, partnerships, collaborations, and events.All News & Events